119 related articles for article (PubMed ID: 37805836)
1. Utilization of Antiviral Therapy for Patients With Hepatitis B-Related Hepatocellular Carcinoma: A Nationwide Real-World US Study.
Kudaravalli S; Kam LY; Huang DQ; Cheung R; Nguyen MH
Clin Gastroenterol Hepatol; 2023 Dec; 21(13):3305-3313.e4. PubMed ID: 37805836
[TBL] [Abstract][Full Text] [Related]
2. Reduced Incidence of Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis B Treated With Tenofovir-A Propensity Score-Matched Study.
Nguyen MH; Yang HI; Le A; Henry L; Nguyen N; Lee MH; Zhang J; Wong C; Wong C; Trinh H
J Infect Dis; 2019 Jan; 219(1):10-18. PubMed ID: 29982737
[TBL] [Abstract][Full Text] [Related]
3. Treatment rates and factors associated with direct-acting antiviral therapy for insured patients with hepatitis C-related hepatocellular carcinoma - A real-world nationwide study.
Kam LY; Yeo YH; Ji F; Henry L; Cheung R; Nguyen MH
Aliment Pharmacol Ther; 2024 Feb; 59(3):350-360. PubMed ID: 37937485
[TBL] [Abstract][Full Text] [Related]
4. Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy.
Yang HI; Yeh ML; Wong GL; Peng CY; Chen CH; Trinh HN; Cheung KS; Xie Q; Su TH; Kozuka R; Lee DH; Ogawa E; Zhao C; Ning HB; Huang R; Li J; Zhang JQ; Ide T; Xing H; Iwane S; Takahashi H; Wong C; Wong C; Lin CH; Hoang J; Le A; Henry L; Toyoda H; Ueno Y; Gane EJ; Eguchi Y; Kurosaki M; Wu C; Liu C; Shang J; Furusyo N; Enomoto M; Kao JH; Yuen MF; Yu ML; Nguyen MH
J Infect Dis; 2020 Jan; 221(3):389-399. PubMed ID: 31550363
[TBL] [Abstract][Full Text] [Related]
5. Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population.
Gordon SC; Lamerato LE; Rupp LB; Li J; Holmberg SD; Moorman AC; Spradling PR; Teshale EH; Vijayadeva V; Boscarino JA; Henkle EM; Oja-Tebbe N; Lu M;
Clin Gastroenterol Hepatol; 2014 May; 12(5):885-93. PubMed ID: 24107395
[TBL] [Abstract][Full Text] [Related]
6. Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma.
Huang DQ; Hoang JK; Kamal R; Tsai PC; Toyoda H; Yeh ML; Yasuda S; Leong J; Maeda M; Huang CF; Won Jun D; Ishigami M; Tanaka Y; Uojima H; Ogawa E; Abe H; Hsu YC; Tseng CH; Alsudaney M; Yang JD; Yoshimaru Y; Suzuki T; Liu JK; Landis C; Dai CY; Huang JF; Chuang WL; Schwartz M; Dan YY; Esquivel C; Bonham A; Yu ML; Nguyen MH
J Clin Oncol; 2024 Mar; 42(7):790-799. PubMed ID: 38175991
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B Virus-related Care Quality in Patients With Hepatitis B/Human Immunodeficiency Virus Coinfection Versus Hepatitis B Monoinfection: A National Cohort Study.
Lee TH; Hunt CM; Maier MM; Lowy E; Beste LA
Clin Infect Dis; 2022 Oct; 75(9):1529-1536. PubMed ID: 35349635
[TBL] [Abstract][Full Text] [Related]
8. Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study.
Yun B; Ahn SH; Oh J; Yoon JH; Kim BK
Eur J Intern Med; 2023 Jan; 107():66-72. PubMed ID: 36347739
[TBL] [Abstract][Full Text] [Related]
9. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
[TBL] [Abstract][Full Text] [Related]
10. Anti-viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus-related hepatocellular carcinoma: real-world east and west experience.
Chen VL; Yeh ML; Le AK; Jun M; Saeed WK; Yang JD; Huang CF; Lee HY; Tsai PC; Lee MH; Giama N; Kim NG; Nguyen PP; Dang H; Ali HA; Zhang N; Huang JF; Dai CY; Chuang WL; Roberts LR; Jun DW; Lim YS; Yu ML; Nguyen MH
Aliment Pharmacol Ther; 2018 Jul; 48(1):44-54. PubMed ID: 29797518
[TBL] [Abstract][Full Text] [Related]
11. Verification of hepatitis B-related hepatocellular carcinoma predictive models to evaluate the risk of HCC in patients with liver cirrhosis under antiviral treatment.
Huang X; Wang H; Zhang W; Gu E
Eur J Gastroenterol Hepatol; 2022 May; 34(5):546-552. PubMed ID: 35170528
[TBL] [Abstract][Full Text] [Related]
12. Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems.
Wong RJ; Jain MK; Therapondos G; Niu B; Kshirsagar O; Thamer M
Am J Gastroenterol; 2021 Jul; 116(7):1465-1475. PubMed ID: 33661148
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study.
Yang DH; Wang WP; Zhang Q; Pan HY; Huang YC; Zhang JJ
World J Gastroenterol; 2021 May; 27(17):2025-2038. PubMed ID: 34007137
[TBL] [Abstract][Full Text] [Related]
14. Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status.
Kim MN; Hwang SG; Kim BK; Park JY; Kim DY; Han KH; Kim SU; Ahn SH
Gut Liver; 2019 Mar; 13(2):197-205. PubMed ID: 30602075
[TBL] [Abstract][Full Text] [Related]
15. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
[TBL] [Abstract][Full Text] [Related]
16. Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.
Su TH; Hu TH; Chen CY; Huang YH; Chuang WL; Lin CC; Wang CC; Su WW; Chen MY; Peng CY; Chien RN; Huang YW; Wang HY; Lin CL; Yang SS; Chen TM; Mo LR; Hsu SJ; Tseng KC; Hsieh TY; Suk FM; Hu CT; Bair MJ; Liang CC; Lei YC; Tseng TC; Chen CL; Kao JH;
Liver Int; 2016 Dec; 36(12):1755-1764. PubMed ID: 27634134
[TBL] [Abstract][Full Text] [Related]
17. Differential characteristics and outcomes of Asian and non-Asian patients with HBV-related hepatocellular carcinoma.
Huang DQ; Hoang JK; Leong J; Riveiro-Barciela M; Maeda M; Yang JD; Accarino EV; Thin K; Trinh L; Cheung RC; Roberts LR; Buti M; Schwartz M; Nguyen MH
Liver Int; 2021 Aug; 41(8):1922-1932. PubMed ID: 33713386
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B Virus Combo Mutations Improve the Prediction and Active Prophylaxis of Hepatocellular Carcinoma: A Clinic-Based Cohort Study.
Yin J; Wang J; Pu R; Xin H; Li Z; Han X; Ding Y; Du Y; Liu W; Deng Y; Ji X; Wu M; Yu M; Zhang H; Wang H; Thompson TC; Ni W; Cao G
Cancer Prev Res (Phila); 2015 Oct; 8(10):978-88. PubMed ID: 26290395
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy.
Jiang XY; Huang B; Huang DP; Wei CS; Zhong WC; Peng DT; Huang FR; Tong GD
World J Gastroenterol; 2021 Mar; 27(11):1101-1116. PubMed ID: 33776376
[TBL] [Abstract][Full Text] [Related]
20. Delayed viral suppression during antiviral therapy is associated with increased hepatocellular carcinoma rates in HBeAg-positive high viral load chronic hepatitis B.
Nam JY; Chang Y; Cho H; Kang SH; Cho YY; Cho EJ; Lee JH; Yu SJ; Yoon JH; Kim YJ
J Viral Hepat; 2018 May; 25(5):552-560. PubMed ID: 29194870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
